Wakamatsu S, Jojima T, Hashiguchi M, Kishi H, et al. Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor. J Diabetes Complications 2023;38:108650.
PMID: 38035640